Hosted on MSN8mon
In a first, drug to treat vision loss launched pan-India
an injectable medicine for the treatment of vision loss, here on Tuesday. The drug, Vabysmo (faricimab), which was first approved by the US Food and Drug Administration in January 2022 and is ...
Light-activated, drug-carrying liposomes show potential for minimally invasive glaucoma treatments
More than 4 million people in the U.S. have glaucoma, a group of eye diseases that can damage the optic nerve and lead to ...
ophthalmologytimes7d
SpyGlass Pharma completes enrollment in Phase I/II study of its long-term drug delivery platform for glaucoma and ocular hypertension
SpyGlass Pharma completed enrollment in a Phase 1/2 trial evaluating its drug delivery platform for glaucoma and ocular ...